The Campbell's Company reported Q3 earnings with EPS of $0.50 and a 4% drop in organic sales, while EBIT margins fell 300 basis points to 11.6%. Although the Rao’s brand is gaining market share, the Snacks segment struggles with volume and margin pressures, worsened by trends linked to GLP-1 drugs. The company’s high debt level at 3.6x leverage limits share buybacks. Trading at 10 times forward earnings, Campbell's shares appear fairly valued but do not present a strong buying opportunity amid weak consumer demand and margin challenges.
Campbell's Company reported a 4% year-over-year decline in net sales for Q3 FY2026, with softness in both Meals & Beverages and Snacks segments. Inflation and tariff pressures led to a contraction in gross margins, although management's cost controls...
Intel's stock jumped after reports that Google and Nvidia are considering Intel as a backup manufacturer for advanced AI chips, with Google reportedly ordering over 3 million Tensor Processing Units for 2028. Nvidia is also testing Intel's technology...
Campbell Soup Company reported Q3 2026 earnings with an EPS of $0.50, beating analyst estimates of $0.48. However, revenue fell short at $2.37 billion versus the expected $2.38 billion, marking a decline from the previous year. The revenue miss was d...
Campbell’s Company is set to release its fiscal third-quarter earnings before the market opens on Monday. Investors are closely watching to see if the company can stabilize its snacks segment, which has struggled through the first half of the year. T...
US stock markets fell last week despite record highs, with tech and semiconductor shares dropping sharply after a strong May jobs report raised concerns about prolonged Federal Reserve rate hikes. The Nasdaq fell 4.68%, and semiconductor ETFs saw the...
